| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |